Myriad Genetics Case : Genetic Patentability
The Myriad Genetics case examines whether isolated gene sequences are patentable or considered products of nature under US law. The Supreme Court ruled that while gDNA is not…
Myriad Genetics
4 articles
The Gene Returns to its Body
Judge Sweet’s landmark ruling held that isolated gene sequences and their analysis are not patentable under US law. This decision invalidated key BRCA gene patents and marks a…
Gene Sequences and Patents: Australian High Court Narrows Scope
The Australian High Court has narrowed the eligibility of gene patents, particularly concerning isolated DNA sequences in the BRCA1 case. This analysis explores the legal reasoning, statutory interpretation,…
Laws of Nature / State of Art Interface
This post explores how the laws of nature exclusion shapes patent eligibility, especially in biotechnology. It discusses key judicial decisions and the impact of state of the art…